Management of venous thromboembolism in patients with cancer: role of dalteparin
Lori-Ann LinkinsDepartment of Hematology and Thrombosis, McMaster University, Hamilton, Ontario, CanadaAbstract: Cancer is a major risk factor for the development of venous thromboembolism (VTE). Conventional anticoagulant therapy with a vitamin K antagonist is more problematic in cancer patients du...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-04-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/management-of-venous-thromboembolism-in-patients-with-cancer-role-of-d-peer-reviewed-article-VHRM |